Company Description
Tecogen Inc., together with its subsidiaries, designs, manufactures, markets, and maintains ultra-clean cogeneration products for multi-family residential, commercial, recreational and industrial use in the United States and internationally.
It operates through three segments: Products, Services, and Energy Production. The Products segment designs, manufactures, and sells industrial and commercial cogeneration systems.
Its Services segment provides operations and maintenance services for products under long term service contracts.
The Energy Production segment sells energy in the form of electricity, heat, hot water, and cooling to customers.
The company also offers natural gas-powered cogeneration systems, chillers, and heat pumps products for water and space heating, and air conditioning.
Its product portfolio includes InVerde e+ and TecoPower, cogeneration units for the supply electricity and hot water; Tecochill, an air-conditioning and refrigeration chillers, and hybrid-drive air-cooled and gas engine-driven chillers to produce chilled water and hot water; Tecofrost, a gas engine-driven refrigeration compressors to circulate refrigerant and provide hot water as a byproduct; and Ultera, an emissions control technology.
In addition, the company provides long-term maintenance contracts, parts sales, and turnkey installation for products through a network of field service centers.
The company sells its products to healthcare, housing and hospitality, education and government, industrial, agriculture, and breweries markets through in-house marketing, as well as independent sales agents and representatives.
Tecogen Inc. was incorporated in 2000 and is headquartered in Waltham, Massachusetts.
Country | United States |
IPO Date | May 20, 2014 |
Industry | Electrical Equipment & Parts |
Sector | Industrials |
Employees | 92 |
CEO | Dr. Abinand Rangesh Ph.D. |
Contact Details
Address: 45 First Avenue Waltham, Massachusetts 02451 United States | |
Phone | 781-466-6400 |
Website | tecogen.com |
Stock Details
Ticker Symbol | TGEN |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001537435 |
CUSIP Number | 87876P201 |
ISIN Number | US87876P2011 |
Employer ID | 04-3536131 |
SIC Code | 3585 |
Key Executives
Name | Position |
---|---|
Dr. Abinand Rangesh Ph.D. | Chief Executive Officer, Chief Financial Officer, Treasurer and Director |
Robert A. Panora | President and Chief Operating Officer |
John Kimball Whiting IV, J.D., MBA | General Counsel and Secretary |
Jeffrey H. Glick | Vice President of Sales |
Roger P. Deschenes | Chief Accounting Officer |
Barbara-Ann Bernard | Managing Director of Communications |
Tristen Howell | Office Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 12, 2024 | PRE 14A | Other preliminary proxy statements |
Mar 25, 2024 | 10-K | Annual Report |
Mar 14, 2024 | 8-K | Current Report |
Mar 7, 2024 | 8-K | Current Report |
Feb 5, 2024 | 8-K | Current Report |
Jan 16, 2024 | 8-K | Current Report |
Dec 14, 2023 | 8-K | Current Report |
Nov 9, 2023 | 10-Q | Quarterly Report |
Nov 8, 2023 | 8-K | Current Report |
Oct 10, 2023 | 8-K | Current Report |